Jacob Chacko, President and CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 5,764 shares at $3.25 ($19K) on 2022-12-15, disclosed to the SEC on 2022-12-16.
Open-market sale of $19k ORIC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |